Mortgage Blog
Caron Treatment Centers brings in new CEO from Betty Ford Foundation
Former CEO Bradley F. Sorte stepped down in February citing a desire to spend more time with his family.
Ohio appeals court awards new trial to fugitive spine surgeon Dr. Atiq Durrani, voids $4.6 million jury award
Dr. Atiq Durrani will get at least six new trials after an Ohio appeals court overturned jury verdicts against him, voiding nearly $10 million in court-awarded damages.
PNC CEO teases new savings program aimed at 2024 bottom line
PNC wants to invest in its new markets, CEO says at Barclays conference.
Tampa ‘blank check’ fund races against deadline for $150M merger deal
The fund is seeking shareholder support ahead of its deadline to merge with a medical device company later this month.
HamptonRock Partners snags Houlihan Lokey team as it looks to grow
HamptonRock Partners has picked up a team from Houlihan Lokey to help launch its Houston office. The Dallas-based investment banking and advisory firm has also added a new service line.
Activist investor Starboard says GoDaddy underperforming, should consider sale
One of GoDaddy's largest shareholders is urging the company to explore a potential sale if it's unable to improve its financial performance. Here's how the move is affecting GoDaddy shares on Wall Street.
Public company sells two of its Orlando area nursing homes
The Orange County property sold for more than $15 million.
Ohio State med school research again sets record
Medical research spans from underlying biology to therapeutic advancements approved for treating patients, plus public health initiatives and the clinical trials needed to get market approval.
Wisconsin hospitals continue to recover from weeks-long system outage
Hospital Systems Health System of Illinois and Prevea Health of Green Bay said Tuesday morning that functionality has been restored to its Epic electronic medical records system following a more than two-week outage related to a “cybersecurity incident.”
CVS shuffles C-suite amid headwinds
CVS spent $19 billion on two recent healthcare M&As, but the markets have yet to show enthusiasm.